INNOVIS HEALTH
1. Target Overview & Investment Thesis
INNOVIS HEALTH is a 142-bed suburban community hospital in CASS, ND with $537.9M in net patient revenue and a -5.3% operating margin. The hospital serves a payer mix of 38.3% Medicare, 8.3% Medicaid, and 53.3% commercial.
Thesis: Undervalued. Our ML models identify $39.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.3% to 2.1% (+736bps).
| Net Revenue HCRIS | $537.9M |
| Current EBITDA COMPUTED | $-28.3M |
| Operating Margin COMPUTED | -5.3% |
| Occupancy HCRIS | 86.8% |
| Revenue / Bed COMPUTED | $3.8M |
| Net-to-Gross HCRIS | 38.5% |
| Distress Probability ML | 38.6% |
2. Market Context & Competitive Position
ND has 52 Medicare-certified hospitals with a median operating margin of -9.3%. The target's margin of -5.3% places it above the state median. Among 2069 size-comparable peers (71-284 beds), the median margin is -3.3%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (71-284), prioritizing same-state peers. 2069 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| INNOVIS HEALTH (Target) | ND | 142 | $537.9M | -5.3% |
| RAINBOW BABIES & CHILDRENS HOS | OH | 231 | $2.22B | -5.0% |
| MOFFITT CANCER CENTER | FL | 218 | $1.91B | 16.0% |
| CITY OF HOPE NATIONAL MEDICAL | CA | 217 | $1.83B | -10.7% |
| MIDWESTERN REGIONAL MEDICAL CE | IL | 73 | $1.38B | 80.5% |
| HOSPITAL FOR SPECIAL SURGERY | NY | 200 | $1.12B | -29.3% |
| VIRGINIA MASON MEDICAL CENTER | WA | 222 | $1.11B | -23.2% |
| CALIFORNIA PACIFIC MEDICAL CEN | CA | 274 | $987.8M | -18.5% |
| DELL CHILDRENS MEDICAL CENTER | TX | 262 | $901.9M | 25.5% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $39.6M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $11.3M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $10.8M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $10.7M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $6.5M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $344K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-28.3M |
| + RCM Uplift | +$39.6M |
| Pro Forma EBITDA | $11.3M |
| Current Margin | -5.3% |
| Pro Forma Margin | 2.1% |
| WC Released (1x) | $20.6M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-43.5M | $209.5M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-43.5M | $216.4M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-39.1M | $332.9M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-39.1M | $351.6M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-47.8M | $25.7M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-47.8M | $12.7M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 2069 hospitals with 71-284 beds
- Same-state prioritization (n=7)
- Comp margins: P25=-13.8% / P50=-3.3% / P75=7.1%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.